TSXV - Delayed Quote • CAD
Quest PharmaTech Inc. (QPT.V)
At close: April 25 at 9:49 AM EDT
Breakdown
TTM
1/31/2023
1/31/2022
1/31/2021
Operating Expense
1,180.4220
834.2160
790.5730
1,070.3460
Operating Income
-1,180.4220
-834.2160
-790.5730
-1,070.3460
Net Non Operating Interest Income Expense
-20.5610
-21.0020
-13.0630
-5.9410
Other Income Expense
-21,057.0480
-6,477.0970
-84,234.9380
191,140.7560
Pretax Income
-22,258.0310
-7,332.3150
-85,038.5740
190,064.4690
Net Income Common Stockholders
-22,258.0310
-7,332.3150
-85,038.5750
190,064.4690
Diluted NI Available to Com Stockholders
-22,258.0310
-7,332.3150
-85,038.5750
190,064.4690
Basic EPS
-0.12
-0.04
-0.51
1.11
Diluted EPS
-0.12
-0.04
-0.51
1.11
Basic Average Shares
168,678.1600
168,395.4680
168,239.2470
167,789.5760
Diluted Average Shares
168,678.1600
168,395.4680
168,239.2470
167,789.5760
Total Expenses
1,180.4220
834.2160
790.5730
1,070.3460
Net Income from Continuing & Discontinued Operation
-22,258.0310
-7,332.3150
-85,038.5750
190,064.4690
Normalized Income
-20,551.4220
-3,801.4900
-58,316.4600
170,397.9887
Interest Income
--
--
--
1.8250
Interest Expense
20.5610
21.0020
13.0630
7.7660
Net Interest Income
-20.5610
-21.0020
-13.0630
-5.9410
EBIT
-22,237.4700
-7,311.3130
-85,025.5110
190,072.2350
EBITDA
-22,234.1860
-7,297.8270
-84,986.9490
190,111.5420
Reconciled Depreciation
3.2840
13.4860
38.5620
39.3070
Net Income from Continuing Operation Net Minority Interest
-22,258.0310
-7,332.3150
-85,038.5750
190,064.4690
Total Unusual Items Excluding Goodwill
-1,706.6090
-3,530.8250
-26,722.1150
26,757.1160
Total Unusual Items
-1,706.6090
-3,530.8250
-26,722.1150
26,757.1160
Normalized EBITDA
-20,527.5770
-3,767.0020
-58,264.8340
163,354.4260
Tax Rate for Calcs
--
--
--
0.0003
Tax Effect of Unusual Items
--
--
--
7,090.6357
1/31/2021 - 6/3/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WESA-X.CN Wesana Health Holdings Inc.
0.0350
+250.00%
ABRT.CN Albert Labs International Corp.
0.0150
+50.00%
ENSC Ensysce Biosciences, Inc.
0.5467
-2.13%
AUPH Aurinia Pharmaceuticals Inc.
4.8700
-3.18%
TRVN Trevena, Inc.
0.4090
+7.35%
HEPA Hepion Pharmaceuticals, Inc.
1.2900
-2.27%
KTRA Kintara Therapeutics, Inc.
0.1580
+15.08%
NRXP NRx Pharmaceuticals, Inc.
3.1400
+0.64%
ABVC ABVC BioPharma, Inc.
1.5900
+7.43%
JAGX Jaguar Health, Inc.
0.1700
+0.06%